▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3020 by analyst upside · 2026-09-27
CBLL
CeriBell, Inc.
Healthcare · Market Cap $909M · P/E 0x
ANALYST PRICE TARGET
+18.2%
implied upside to consensus target
Current Price $23.69
Consensus Target $28.0
Bull Target $32.0
Bear Target $24.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
6
Hold
0
Sell
0
52-Week Low $10.85
52-Week High $25.63
YTD Return +11.2%
FUNDAMENTALS
Market Cap $909M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.76
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $102M
Profit Margin -64.7%
52-WEEK RANGE
52-Week Low $10.85
52-Week High $25.63
Current Price $23.69
Bear Target $24.0
Bull Target $32.0
● Now $23.69 ● Target $28.0
TRADING DATA
Avg Volume 386K
YTD Return +11.2%
Analyst Count 7
Consensus Buy
Upside to Target +18.2%
Last Updated 2026-09-27

ANALYST SUMMARY

CeriBell, Inc. (CBLL) is currently trading at $23.69 with a Wall Street consensus price target of $28.0, implying potential upside of 18.2% over the next 12 months. 7 analysts currently cover CBLL, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $32.0, while the most cautious has a target of $24.0.

CBLL operates in the Healthcare sector with a market capitalisation of $909M. The stock is up 11.2% year-to-date and is currently trading near the upper end of its 52-week range of $10.85 – $25.63.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CBLL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BTIG reit
Buy → Buy 2026-09-11 38% win rate (8 calls)
BTIG - Reiterated
Buy → Buy 2026-08-18 38% win rate (8 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2026-08-11 Building track record
BTIG reit
Buy → Buy 2026-08-11 38% win rate (8 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2026-05-12 Building track record
BTIG reit
Buy → Buy 2026-01-28 38% win rate (8 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2025-12-17 Building track record
BTIG reit
Buy → Buy 2025-12-15 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
66
out of 100
Coverage depth
16/30
Consensus clarity
23/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →